Death by a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP+) and protection by EGF in GH3 cells

Brain Research

Volumn 794, Issue 1, 1998, Pages 137-142

  Yoshinaga, Norihiro ^a   Murayama, Toshihiko ^a   Nomura, Yasuyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cell death; GH3 cell; MPP+; Neurotrophic factor

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; EPIDERMAL GROWTH FACTOR; NERVE GROWTH FACTOR; NEUROTOXIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STRAIN GH3; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL DEATH; CLONE CELLS; DOPAMINE; DOPAMINE AGENTS; EPIDERMAL GROWTH FACTOR; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PITUITARY GLAND, ANTERIOR; RATS; TYROSINE 3-MONOOXYGENASE;

EID: 0032565640     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00225-X     Document Type: Article

References (38)

1. T. Amano, H. Ujikara, H. Matsubayashi, M. Sasa, T. Yokota, Y. Tamura, A. Akaike, Dopamine-induced protection of striatal neurons against kainate receptor-mediated glutamate cytotoxicity in vitro, Brain Res. 655 (1994) 61-69.
2. P.A. Ballard, J.W. Tetrud, J.W. Langston, Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases, Neurology 35 (1985) 949-956.
3. K. Bankiewicz, E. Oldfield, C. Chiueh, J. Doppman, D. Jacobowitz, I. Kopin, Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Life Sci. 39 (1986) 7-16.
4. R.S. Burns, C.C. Chiueh, S.P. Markey, M.H. Ebert, D.M. Jacobowitz, I. Kopin, A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 4546-4550.
5. +, a metabolite of MPTP, by brain synaptosomes, Biochem. Biophys. Res. Commun. 128 (1985) 1228-1232.
6. M.J. Cronin, N. Faure, J.A. Martial, R.I. Weiner, Absence of high affinity dopamine receptors in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine, Endocrinology 106 (1980) 718-723.
7. +-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport, Brain Res. 715 (1996) 1-8.
8. 2-receptors in retinoic acid induced differentiated human neuroblastoma SH-SY5Y cells, Life Sci. 55 (1994) 1887-1893.
9. B. Giros, S.E. Mestikawy, N. Godinot, K. Zheng, H. Han, T. Yang-Feng, M.G. Caron, Cloning, pharmacological characterization and chromosome assignment of the human dopamine transporter, Mol. Pharmacol. 42 (1992) 383-390.
10. M. Hadjiconstantinou, J.G. Fitkin, A. Dalia, N.H. Neff, Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, J. Neurochem. 57 (1991) 479-482.
11. H. Hasegawa, T. Murayama, A. Takahashi, C. Itakura, Y. Nomura, The monoamine content of the brain in the neurofilament-deficient quail (the quiver quail), Biol. Pharm. Bull. 17 (1994) 1053-1055.
12. H. Hatanaka, Nerve growth factor-mediated stimulation of tyrosine hydroxylase activity in a clonal of rat pheochromocytoma cell line, Brain Res. 222 (1981) 225-233.
13. +) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms, Brain Res. 704 (1995) 240-245.
14. +)-induced cell death in PC 12 cells: inhibitory effects of several drugs, Neurochem. Int. 25 (1994) 419-424.
15. +, a possible parkinsonism inducer, on dopamine content and tyrosine hydroxylase mRNA expression in PC12 cells, Neurochem. Int. 26 (1995) 165-171.
16. J.A. Javitch, R.J. D'Amato, S.M. Strittmatter, S.H. Snyder, Parkinsonian-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity, Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 2173-2177.
17. T. Kondo, T. Ito, Y. Sugita, Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum, Neurobiology 738 (1994) 222-229.
18. J.W. Langston, P. Ballard, I. Irwin, Chronic parkinsonism in human due to a product of meperidine-analog synthesis, Science 219 (1983) 979-980.
19. +): identification of a metabolite of MPTP, a toxin selective to the substantia nigra, Neurosci. Lett. 48 (1984) 87-92.
20. W.B. Malarkey, J.C. Groshong, G.E. Milo, Defective dopaminergic regulation of prolactin secretion in a rat pituitary tumour cell line, Nature 266 (1977) 640-641.
21. J.M. Masserano, L. Gong, H. Kulaga, I. Baker, R.J. Wyatt, Dopamine induces apoptotic cell death of a catecholaminergic cell line derived from the central nervous system, Mol. Pharmacol. 50 (1996) 1309-1315.
22. 2-receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor, J. Biol. Chem. 266 (1991) 23392-23398.
23. C. Missale, L. Castelletti, F. Boroni, M. Memo, P. Spano, Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line, Endocrinology 128 (1991) 13-20.
24. Y. Mizuno, N. Sone, T. Saitoh, Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridium ion on activities of the enzymes in the electron transport system in mouse brain, J. Neurochem. 48 (1987) 1787-1793.
25. 2L receptors in human neuroblastoma SH-SY5Y cells, J. Neurochem. 66 (1996) 2390-2393.
26. W.J. Nicklas, I. Vyas, R.E. Heikkila, Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, Life Sci. 36 (1985) 2503-2508.
27. 2+], elevation or noradrenaline release in PC12 cells, Arch. Biochem. Biophys. 332 (1996) 1-7.
28. H. Oda, T. Murayama, Y. Nomura, Inhibition of protein kinase C-dependent noradrenaline release by wortmannin in PC12 cells, Arch. Biochem. Biophys. 337 (1997) 96-102.
29. N. Ogawa, K. Tanaka, M. Asanuma, M. Kawai, T. Masumizu, M. Kohno, A. Mori, Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro, Brain Res. 657 (1994) 207-213.
30. +, Biochem. Biophys. Res. Commun. 134 (1986) 743-748.
31. +) and its analogs with the rotenone/piericidine binding site of NADH dehydrogenase, J. Neurochem. 56 (1991) 1184-1190.
32. R. Rebois, E.E. Reynolds, L. Toll, B.D. Howard, Storage of dopamine and acetylcholine in granules of PC12, a clonal pheochromocytoma cell lone, Biochemistry 19 (1980) 1240-1248.
33. M. Santiago, A. Machado, J. Cano, Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system, J. Neurochem. 66 (1996) 1182-1190.
34. J.W. Snyder, J.G. Pastorino, A.M. Attie, J.L. Farber, Protection by cyclosporin A of cultured hepatocytes from the toxin consequences of the loss of mitochondrial energization produced by 1-methyl-4-phenylpyridinium, Biochem. Pharmacol. 44 (1992) 833-835.
35. M.B. Spina, S.P. Squinto, J. Miller, R.M. Lindsay, C. Hyman, Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system, J. Neurochem. 59 (1992) 99-106.
36. A.H. Tashjian, F.C. Bancroft, L. Levine, G.H. Sato, M.L. Parker, Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone, Endocrinology 82 (1968) 342-352.
37. A.H. Tashjian, F.C. Bancroft, L. Levine, Production of both prolactin and growth hormone by clonal strains of rat pituitary cells, J. Cell. Biol. 47 (1970) 61-70.
38. T. Yoshikawa, Y. Minamiyama, Y. Naito, M. Kondo, Anti-oxidant properties of bromocriptine, a dopamine agonist, J. Neurochem. 62 (1994) 1034-1038.